| Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review R Margiana, A Markov, AO Zekiy, MU Hamza, KA Al-Dabbagh, ... Stem Cell Research & Therapy 13 (1), 366, 2022 | 106 | 2022 |
| Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke S Dolati, M Ahmadi, M Khalili, AA Taheraghdam, H Siahmansouri, ... Neurological Sciences 39, 647-654, 2018 | 86 | 2018 |
| Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells V Alinejad, MH Somi, B Baradaran, P Akbarzadeh, F Atyabi, H Kazerooni, ... Biomedicine & Pharmacotherapy 83, 229-240, 2016 | 84 | 2016 |
| Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line H Siahmansouri, MH Somi, Z Babaloo, B Baradaran, F Jadidi-Niaragh, ... Journal of Pharmacy and Pharmacology 68 (9), 1119-1130, 2016 | 70 | 2016 |
| Intrauterine administration of autologous hCG-activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double … Z Pourmoghadam, MS Soltani-Zangbar, G Sheikhansari, R Azizi, ... Journal of Reproductive Immunology 142, 103182, 2020 | 36 | 2020 |
| Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer A Afkham, L Aghebati-Maleki, H Siahmansouri, S Sadreddini, M Ahmadi, ... Pharmacological Reports 70 (3), 418-425, 2018 | 36 | 2018 |
| Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells W Suksatan, S Chupradit, AV Yumashev, S Ravali, MN Shalaby, ... International Immunopharmacology 101, 108217, 2021 | 30 | 2021 |
| Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial M Ahmadi, S Abdolmohamadi-Vahid, M Ghaebi, S Dolati, ... International Immunopharmacology 74, 105730, 2019 | 30 | 2019 |
| Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells H Huldani, R Margiana, F Ahmad, MJC Opulencia, MJ Ansari, DO Bokov, ... International immunopharmacology 107, 108698, 2022 | 25 | 2022 |
| Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study M Dauletova, H Hafsan, N Mahhengam, AO Zekiy, M Ahmadi, ... Clinical Immunology 226, 108712, 2021 | 25 | 2021 |
| Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival AH Amin, LM Al Sharifi, AJ Kakhharov, MJC Opulencia, F Alsaikhan, ... Biomedicine & Pharmacotherapy 150, 113009, 2022 | 20 | 2022 |
| Applications of microfluidic devices in the diagnosis and treatment of cancer: A review study N Mahhengam, A fahem ghetran Khazaali, S Aravindhan, ... Critical reviews in analytical chemistry 52 (8), 1863-1877, 2022 | 17 | 2022 |
| Mechanisms of cancer stem cells drug resistance and the pivotal role of HMGA2 H Huldani, SA Jasim, KN Sergeenva, DO Bokov, WK Abdelbasset, ... Pathology-Research and Practice 234, 153906, 2022 | 13 | 2022 |
| Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation MS Soltani-Zangbar, L Aghebati-Maleki, M Hajivalili, M Haji-Fatahaliha, ... Gene Reports 23, 101140, 2021 | 12 | 2021 |
| Shining the light on mesenchymal stem cell-derived exosomes in breast cancer GRL Al-Awsi, F Alsaikhan, R Margiana, I Ahmad, I Patra, MAA Najm, ... Stem Cell Research & Therapy 14 (1), 21, 2023 | 10 | 2023 |
| Targeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach N Mahhengam, K Kazemnezhad, H Setia Budi, MJ Ansari, ... Journal of Drug Targeting 30 (5), 494-510, 2022 | 7 | 2022 |
